Epigenetics: Critical Driver Shaping the Rising Cancer Prevalence And Other Diseases Driving Demand For Epigenetics Market Market in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Epigenetics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for epigenetics has seen a significant expansion in the last few years. The market is projected to escalate from $10.65 billion in 2024 to $12.83 billion in 2025, displaying a compound annual growth rate (CAGR) of 20.4%. The historical growth increase can be associated with factors such as augmented funding for research, a surge in chronic disease cases, the rise of personalized medicine, advancements in cancer research, and an aging population.

Epigenetics Market Size Forecast: What's the Projected Valuation by 2029?
The market size of epigenetics is predicted to undergo a massive expansion in the upcoming years, swelling to a value of $29.08 billion in 2029 with a compound annual growth rate (CAGR) of 22.7%. The surge during the forecast period can be credited to factors such as the development of epigenetic drugs, the role of epigenetics in environmental health and precision agriculture, regulatory backing, and increased patient awareness and advocacy. Noteworthy trends during the forecast period include epitranscriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers, research on aging and longevity, and interactions between the microbiome and epigenome.

View the full report here:
https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

What Are the Drivers Transforming the Epigenetics Market?
The escalating incidence of cancer and other medical conditions is playing a significant role in propelling the growth of the epigenetics market. The demand for epigenetics escalates as the incidence of illnesses rises. As reported by the National Cancer Institute (NCI), a U.S.-based governmental body, in May 2024, there were about 20 million new cases of cancer in 2022, leading to roughly 9.7 million deaths associated with the disease. Forecasts allude that by 2040, the annual rate of new cancer instances will rise to 29.9 million, with cancer-related fatalities reaching 15.3 million. Additionally, the Centers for Disease Control and Prevention (CDC) reveals that nearly 659,000 individuals in the United States die from heart disease annually. The rising frequency of cancer and other medical conditions necessitates testing and understanding the changes that occur in genes, which will in turn, lead to increased usage and demand for epigenetics. Hence, the escalating incidence of cancer and other illnesses will be a driving factor for the epigenetics market in the future years.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

What Long-Term Trends Will Define the Future of the Epigenetics Market?
Leading firms in the epigenetics market are turning their focus to the evolution of technologically superior solutions such as DNA sequencing methods. This shift aims to bolster precision medicine and enrich understanding and outcomes of disease treatment. DNA sequencing methods serve as key tools for identifying the sequence of nucleotides within a DNA molecule, thus facilitating thorough genetic examination. Such data plays a pivotal role in detecting variations in genetics linked to diseases, subsequently driving the advances in precision medicine. A case in point is Illumina Inc., an American biotechnology company, which introduced Illumina Complete Long Read Technology in March 2023. This technology allows for both long-read and short-read sequencing within a single instrument, greatly expanding flexibility in genomic research. By simplifying the library preparation processes through reduced DNA input necessities and a streamlined workflow, it makes the process manageable for complex samples. Furthermore, the technology's capability to call variants with high accuracy supplies dependable data, which is vital for a wide-ranging genomic analysis.

Which Segments in the Epigenetics Market Offer the Most Profit Potential?
The epigenetics market covered in this report is segmented -

1) By Product: Reagents, Enzymes, Instruments, Kits
2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures
3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications
4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:
1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes
2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes
3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers
4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Which Firms Dominate the Epigenetics Market by Market Share and Revenue in 2025?
Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Which Regions Offer the Highest Growth Potential in the Epigenetics Market?
North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7070

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.